A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 492 participants.
Also called NCT01558271
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 492 participants
- Sponsor
- Registry
-
NCT01558271
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01558271. Randomized; quadruple masking; primary purpose treatment. Start 2012-03 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2014-10-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- LY2189265
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Liraglutide
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01558271- Content hash
d7005909dc5439f6a18881ee8c5ee3a47fd7abe2335f784361dcb8b430158a62